{"pmid":32418055,"title":"COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.","text":["COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.","Coronavirus disease 2019 (COVID-19) was reported at the end of 2019 in China for the first time and has rapidly spread throughout the world as a pandemic. Since COVID-19 causes mild to severe acute respiratory syndrome, most studies in this field have only focused on different aspects of pathogenesis in the respiratory system. However, evidence suggests that COVID-19 may affect the central nervous system (CNS). Given the outbreak of COVID-19, it seems necessary to perform investigations on the possible neurological complications in patients who suffered from COVID-19. Here, we reviewed the evidence of the neuroinvasive potential of coronaviruses and discussed the possible pathogenic processes in CNS infection by COVID-19 to provide a precise insight for future studies.","J Neurovirol","Sepehrinezhad, Ali","Shahbazi, Ali","Negah, Sajad Sahab","32418055"],"abstract":["Coronavirus disease 2019 (COVID-19) was reported at the end of 2019 in China for the first time and has rapidly spread throughout the world as a pandemic. Since COVID-19 causes mild to severe acute respiratory syndrome, most studies in this field have only focused on different aspects of pathogenesis in the respiratory system. However, evidence suggests that COVID-19 may affect the central nervous system (CNS). Given the outbreak of COVID-19, it seems necessary to perform investigations on the possible neurological complications in patients who suffered from COVID-19. Here, we reviewed the evidence of the neuroinvasive potential of coronaviruses and discussed the possible pathogenic processes in CNS infection by COVID-19 to provide a precise insight for future studies."],"journal":"J Neurovirol","authors":["Sepehrinezhad, Ali","Shahbazi, Ali","Negah, Sajad Sahab"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32418055","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s13365-020-00851-2","keywords":["covid-19","coronavirus","nervous system","neuroinvasion","transmission routes"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1667058206766006272,"score":9.490897,"similar":[{"pmid":32474399,"title":"Infectivity of human coronavirus in the brain.","text":["Infectivity of human coronavirus in the brain.","A new strain of human coronaviruses (hCoVs), Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been identified to be responsible for the current outbreak of the coronavirus disease 2019 (COVID-19). Though major symptoms are primarily generated from the respiratory system, neurological symptoms are being reported in some of the confirmed cases, raising concerns of its potential for intracranial invasion and neurological manifestations, both in the acute phase and in the long-term. At present, it remains unclear the extent to which SARS-CoV-2 is present in the brain, and if so, its pathogenic role in the central nervous system (CNS). Evidence for neuroinvasion and neurovirulence of hCoVs has been recognised in animal and human studies. Given that SARS-CoV-2 belongs to the same family and shares characteristics in terms of receptor binding properties, it is worthwhile exploring its potential CNS manifestations. This review summarises previous findings from hCoVs in relation to the CNS, and compares these with the new strain, aiming to provide a better understanding of the effects of SARS-CoV-2 on the CNS.","EBioMedicine","Cheng, Qi","Yang, Yue","Gao, Jianqun","32474399"],"abstract":["A new strain of human coronaviruses (hCoVs), Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been identified to be responsible for the current outbreak of the coronavirus disease 2019 (COVID-19). Though major symptoms are primarily generated from the respiratory system, neurological symptoms are being reported in some of the confirmed cases, raising concerns of its potential for intracranial invasion and neurological manifestations, both in the acute phase and in the long-term. At present, it remains unclear the extent to which SARS-CoV-2 is present in the brain, and if so, its pathogenic role in the central nervous system (CNS). Evidence for neuroinvasion and neurovirulence of hCoVs has been recognised in animal and human studies. Given that SARS-CoV-2 belongs to the same family and shares characteristics in terms of receptor binding properties, it is worthwhile exploring its potential CNS manifestations. This review summarises previous findings from hCoVs in relation to the CNS, and compares these with the new strain, aiming to provide a better understanding of the effects of SARS-CoV-2 on the CNS."],"journal":"EBioMedicine","authors":["Cheng, Qi","Yang, Yue","Gao, Jianqun"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474399","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ebiom.2020.102799","keywords":["brain","coronavirus","human","neuroinvasion","neurological manifestation","sars-cov-2"],"topics":["Mechanism"],"weight":1,"_version_":1668341932656427008,"score":239.9577},{"pmid":32455089,"pmcid":"PMC7243063","title":"A Review of Neurological Complications of COVID-19.","text":["A Review of Neurological Complications of COVID-19.","The SARS-CoV-2, a novel virus has shown an association with central nervous system (CNS) symptoms. Initial retrospective studies emerging from China and France, as well as case reports from different parts of the world revealed a spectrum of neurological symptoms ranging from a simple headache to more serious encephalitis and dysexecutive syndromes. Authors have tried to explain this neurotropism of the virus by comparing invasion mechanisms with prior epidemic coronavirus like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Concrete evidence on those viruses has been limited. This review attempts to discuss various pathophysiological mechanisms as it relates to neurological complications of SARS-CoV-2. We will also discuss the neurological manifestations seen in various retrospective studies, systemic reviews, and case reports.","Cureus","Sheraton, Mack","Deo, Neha","Kashyap, Rahul","Surani, Salim","32455089"],"abstract":["The SARS-CoV-2, a novel virus has shown an association with central nervous system (CNS) symptoms. Initial retrospective studies emerging from China and France, as well as case reports from different parts of the world revealed a spectrum of neurological symptoms ranging from a simple headache to more serious encephalitis and dysexecutive syndromes. Authors have tried to explain this neurotropism of the virus by comparing invasion mechanisms with prior epidemic coronavirus like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Concrete evidence on those viruses has been limited. This review attempts to discuss various pathophysiological mechanisms as it relates to neurological complications of SARS-CoV-2. We will also discuss the neurological manifestations seen in various retrospective studies, systemic reviews, and case reports."],"journal":"Cureus","authors":["Sheraton, Mack","Deo, Neha","Kashyap, Rahul","Surani, Salim"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32455089","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.7759/cureus.8192","keywords":["cns complications","coronavirus","covid-19","guillian barre syndrome","neurology","sars-cov-2"],"locations":["China","France"],"countries":["China","France"],"countries_codes":["CHN|China","FRA|France"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1667881798378455040,"score":204.33325},{"pmid":32451846,"pmcid":"PMC7247778","title":"Does SARS-CoV-2 infection cause chronic neurological complications?","text":["Does SARS-CoV-2 infection cause chronic neurological complications?","The current pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has created an unparalleled health crisis. Besides the acute respiratory infection, CoVs are neuroinvasive causing additional inflammation and neurodegeneration. This is likely also true of SARS-CoV-2 given reports of neurological manifestations in coronavirus disease 2019 (COVID-19) positive patients. Older adults > 65 years of age constitute a high-risk group prone to severe infection and death. Despite the higher mortality rate, a majority of cases are expected to recover and survive from this viral outbreak. But, the long-term consequences of SARS-CoV-2 neuroinfection are unknown. We discuss these potential chronic changes to the central nervous system (CNS) in relation to accelerated brain aging and age-related neurodegenerative disorders.","Geroscience","Hascup, Erin R","Hascup, Kevin N","32451846"],"abstract":["The current pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has created an unparalleled health crisis. Besides the acute respiratory infection, CoVs are neuroinvasive causing additional inflammation and neurodegeneration. This is likely also true of SARS-CoV-2 given reports of neurological manifestations in coronavirus disease 2019 (COVID-19) positive patients. Older adults > 65 years of age constitute a high-risk group prone to severe infection and death. Despite the higher mortality rate, a majority of cases are expected to recover and survive from this viral outbreak. But, the long-term consequences of SARS-CoV-2 neuroinfection are unknown. We discuss these potential chronic changes to the central nervous system (CNS) in relation to accelerated brain aging and age-related neurodegenerative disorders."],"journal":"Geroscience","authors":["Hascup, Erin R","Hascup, Kevin N"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451846","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s11357-020-00207-y","keywords":["aging","alzheimer's disease","covid-19","cellular senescence","neurodegeneration","neurotropism"],"topics":["Mechanism"],"weight":1,"_version_":1667983494534397953,"score":200.64351},{"pmid":32463395,"title":"The involvement of the central nervous system in patients with COVID-19.","text":["The involvement of the central nervous system in patients with COVID-19.","Coronaviruses disease (COVID-19) has caused major outbreaks. A novel variant, SARS-CoV-2, is responsible for COVID-19 pandemic. Clinical presentations and pathological mechanisms of COVID-19 are broad. The respiratory aspect of the disease has been extensively researched. Emerging studies point out the possibility of the central nervous system (CNS) involvement by COVID-19. Here, we discuss the current evidence for CNS involvement in COVID-19 and highlight that the high pathogenicity of SARS-CoV-2 might be due to its neuroinvasive potential.","Rev Neurosci","Saleki, Kiarash","Banazadeh, Mohammad","Saghazadeh, Amene","Rezaei, Nima","32463395"],"abstract":["Coronaviruses disease (COVID-19) has caused major outbreaks. A novel variant, SARS-CoV-2, is responsible for COVID-19 pandemic. Clinical presentations and pathological mechanisms of COVID-19 are broad. The respiratory aspect of the disease has been extensively researched. Emerging studies point out the possibility of the central nervous system (CNS) involvement by COVID-19. Here, we discuss the current evidence for CNS involvement in COVID-19 and highlight that the high pathogenicity of SARS-CoV-2 might be due to its neuroinvasive potential."],"journal":"Rev Neurosci","authors":["Saleki, Kiarash","Banazadeh, Mohammad","Saghazadeh, Amene","Rezaei, Nima"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463395","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1515/revneuro-2020-0026","keywords":["ace2","covid-19","sars-cov-2","anosmia","central nervous system (cns)","coronavirus"],"topics":["Mechanism"],"weight":1,"_version_":1668079521234944001,"score":190.50298},{"pmid":32483687,"pmcid":"PMC7262683","title":"The neurological manifestations of COVID-19: a review article.","text":["The neurological manifestations of COVID-19: a review article.","RESULTS: Various neurological manifestations have been reported in the literature associated with COVID-19, which in the current study are classified into Central Nervous System (CNS) related manifestations including headache, dizziness, impaired consciousness, acute cerebrovascular disease, epilepsy, and Peripheral Nervous System (PNS) related manifestations such as hyposmia/anosmia, hypogeusia/ageusia, muscle pain, and Guillain-Barre syndrome. CONCLUSION: During the current context of COVID-19 pandemic, physicians should be aware of wide spectrum of neurological COVID-19 sign and symptoms for early diagnosis and isolation of patients. In this regard, COVID-19 has been associated with many neurological manifestations such as confusion, anosmia, and ageusia. Also, various evidences support the possible CNS roles in the COVID-19 pathophysiology. In this regard, further investigation of CNS involvement of SARS-COV-2 is suggested.","Neurol Sci","Niazkar, Hamid Reza","Zibaee, Behdad","Nasimi, Ali","Bahri, Narjes","32483687"],"abstract":["RESULTS: Various neurological manifestations have been reported in the literature associated with COVID-19, which in the current study are classified into Central Nervous System (CNS) related manifestations including headache, dizziness, impaired consciousness, acute cerebrovascular disease, epilepsy, and Peripheral Nervous System (PNS) related manifestations such as hyposmia/anosmia, hypogeusia/ageusia, muscle pain, and Guillain-Barre syndrome. CONCLUSION: During the current context of COVID-19 pandemic, physicians should be aware of wide spectrum of neurological COVID-19 sign and symptoms for early diagnosis and isolation of patients. In this regard, COVID-19 has been associated with many neurological manifestations such as confusion, anosmia, and ageusia. Also, various evidences support the possible CNS roles in the COVID-19 pathophysiology. In this regard, further investigation of CNS involvement of SARS-COV-2 is suggested."],"journal":"Neurol Sci","authors":["Niazkar, Hamid Reza","Zibaee, Behdad","Nasimi, Ali","Bahri, Narjes"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32483687","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s10072-020-04486-3","keywords":["covid-19","coronaviruses","neurological symptoms","sars-cov-2"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1668704334404124672,"score":189.55089}]}